|
Market Closed -
Toronto S.E.
14:47:57 29/10/2026 GMT
|
5-day change | 1st Jan Change | ||
| 4.400 CAD | +2.33% |
|
+2.33% | +285.96% |
| 09-29 | Medicure Inc. Completes Enrollment In Its MEND-PNPO Phase 3 Clinical Trial | CI |
| 09-09 | Medicure Presents Mend-Pnpo Phase 3 Study Design and Baseline Data At the 16Th European Epilepsy Congress | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MEDICURE INC. | Bio Therapeutic Drugs | +2.33% | +2.33% | +285.96% | +327.18% | +363.16% | 32.84M |
-
|
-
|
-
|
- Stock Market
- Stocks
- MPH Stock
- Charts Medicure Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
